Real-time enrollment status for this glioblastoma, idh-wildtype clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:41 AM UTC
| NCT Number | NCT05879367 |
| Recruiting Status | Recruiting |
| Condition | Glioblastoma, IDH-wildtype |
| Phase | Clinical Trial |
| Target Enrollment | 66 participants |
| Active Locations | 8 sites in the US |
| Sponsor | Orbus Therapeutics, Inc. |
| Last Updated on CT.gov | June 25, 2025 (Jun 25, 2025) |
As of July 13, 2026: Clinical trial NCT05879367 is currently recruiting participants. This clinical trial study for glioblastoma, idh-wildtype is actively seeking new participants at 8 locations across the United States. The study is sponsored by Orbus Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05879367 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05879367 was last updated Jun 25, 2025 (June 25, 2025). HelloStudys verifies this status automatically.